Livio Pagano
Università Cattolica del Sacro Cuore
H-index: 77
Europe-Italy
Top articles of Livio Pagano
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape | Infection | Antonio Vena Matteo Bassetti Laura Mezzogori Francesco Marchesi Martin Hoenigl | 2024/2 |
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study | American Journal of Hematology | Andrea Visentin Marina Deodato Candida Vitale Eugenio Galli Alberto Fresa | 2024 |
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey | Leukemia & lymphoma | Shaimaa El-Ashwah Jon Salmanton-García Yavuz M Bilgin Federico Itri Pavel Žák | 2024/1/28 |
Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review | Marianna Criscuolo Maria Elena Tosti Alessandro Broccoli Marzia Varettoni Alessio Maria Edoardo Maraglino | 2024/4/11 | |
CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance and immune homeostasis | Blood | Giorgia Renga Emilia Nunzi Claudia Stincardini Marilena Pariano Matteo Puccetti | 2024/1/18 |
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management | Annals of Hematology | John Donald Marra Filippo Frioni Gessica Minnella Monica Rossi Tanja Malara | 2023/11/29 |
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry | Hematological Oncology | Pellegrino Musto Jon Salmanton‐García Nicola Sgherza Rui Bergantim Francesca Farina | 2024/1 |
NPM1-mutated myeloid neoplasm with low percentage of blasts. | American Journal of Hematology | Brunangelo Falini Patrizia Chiusolo Luana Fianchi Livio Pagano | 2024/2/23 |
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey | Infection | Tobias Lahmer Jon Salmanton-García Francesco Marchesi Shaimaa El-Ashwah Marcio Nucci | 2024/2/22 |
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 | EClinicalMedicine | Jon Salmanton-García Francesco Marchesi Francesca Farina Barbora Weinbergerová Federico Itri | 2024/5/1 |
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA) | Haematologica | Francesco Marchesi Jon Salmanton-García Ziad Emarah Klára Piukovics Marcio Nucci | 2022/5 |
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted | Biomarker Research | Manuela Mancini Cecilia Monaldi Sara De Santis Cristina Papayannidis Michela Rondoni | 2023/3/10 |
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey | Blood Advances | Jaap A van Doesum Jon Salmanton-García Francesco Marchesi Roberta Di Blasi Iker Falces-Romero | 2023/6/13 |
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings | International Journal of Infectious Diseases | Giuseppe Rossi Jon Salmanton-García Chiara Cattaneo Francesco Marchesi Julio Dávila-Valls | 2023/12/1 |
Posaconazole and midostaurin in patients with FLT3‐mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life study | Clinical and Translational Science | Pierantonio Menna Francesco Marchesi Chiara Cattaneo Anna Candoni Mario Delia | 2023/10 |
Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope | Mycoses | Maria Ilaria Del Principe Danila Seidel Marianna Criscuolo Michelina Dargenio Zdenek Racil | 2023/1 |
Unmet clinical needs and management recommendations for blastic plasmacytoid dendritic cell neoplasm: a consensus-based position paper from an ad hoc international expert panel | Hemasphere | Livio Pagano Pier Luigi Zinzani Stefano Pileri Pietro Quaglino Branko Cuglievan | 2023/3/1 |
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: Updated epidemiology and risk factors for multidrug-resistant strains in an … | International Journal of Antimicrobial Agents | Enrico Maria Trecarichi Gabriele Giuliano Chiara Cattaneo Stelvio Ballanti Marianna Criscuolo | 2023/6/1 |
Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm: a 2-speed cure in the United States and European Union | Blood Advances | Caterina Giovanna Valentini Livio Pagano | 2023/11/28 |
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry | International Journal of Antimicrobial Agents | Jon Salmanton-García Francesco Marchesi Philipp Koehler Barbora Weinbergerová Natasa Čolović | 2023/10/1 |
